Cargando…
Evaluation of a Novel Hexavalent Humanized Anti-IGF-1R Antibody and Its Bivalent Parental IgG in Diverse Cancer Cell Lines
A major mechanism of monoclonal antibodies that selectively target the insulin-like growth factor type 1 receptor (IGF-1R) to inhibit tumor growth is by downregulating the receptor, regardless whether they are capable (antagonistic) or incapable (agonistic) of blocking the binding of cognate ligands...
Autores principales: | Chang, Chien-Hsing, Wang, Yang, Trisal, Preeti, Li, Rongxiu, Rossi, Diane L., Nair, Anju, Gupta, Pankaj, Losman, Michele, Cardillo, Thomas M., Rossi, Edmund A., Goldenberg, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432068/ https://www.ncbi.nlm.nih.gov/pubmed/22952934 http://dx.doi.org/10.1371/journal.pone.0044235 |
Ejemplares similares
-
Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitro
por: Cardillo, Thomas M, et al.
Publicado: (2013) -
A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro
por: Chang, Chien-Hsing, et al.
Publicado: (2012) -
Interferon-λ1 Linked to a Stabilized Dimer of Fab Potently Enhances both Antitumor and Antiviral Activities in Targeted Cells
por: Liu, Donglin, et al.
Publicado: (2013) -
Bringing the Heavy Chain to Light: Creating a Symmetric, Bivalent IgG-Like Bispecific
por: Ramasubramanian, Anusuya, et al.
Publicado: (2020) -
Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
por: Maun, Henry R., et al.
Publicado: (2020)